Coagulopathy and leak, specific to the brain vasculature, are central pathogenetic 43 components of cerebral malaria (CM). It is unclear how the parasite, Plasmodium falciparum, 44 triggers these processes. Extracellular histones, released from damaged host cells, bind to cell 45 membranes and cause coagulation activation, platelet aggregation and vascular leak in 46 diverse critical illnesses. In CM patients with P. falciparum, serum histones correlate with 47 fibrin formation, thrombocytopenia, and endothelial activation and predict brain swelling on 48 magnetic resonance imaging and fatal outcome. Post-mortem, histones bind to the luminal 49 vascular surface, co-localizing with P. falciparum-infected erythrocytes (IE), and with 50 thrombosis and leak. Purified P. falciparum histones cause toxicity and barrier disruption in 51 cultured human brain microvascular endothelial cells, as does serum from CM patients, 52 reversed by anti-histone antibodies and non-anticoagulant heparin. These data implicate 53 parasite histones as a key trigger of fatal brain swelling in CM. Neutralizing histones with 54
with its function and the production of aPC (35, 36) . Thus histones released by IE would be 145
predicted to concentrate and be particularly toxic in the brain. 146 147
Supporting that P. falciparum histones may be released in patients with malaria, nucleosomes 148 have been detected in the plasma of South-East Asian adults with malaria, which were higher 149 in severe cases (28) . However the association between nucleosomes (which have minimal 150 toxicity (21)) and free histones is variable and it was not identified whether these 151 nucleosomes were of host or parasite origin, or whether they were active. Thus, it remains 152 uncertain whether significant levels of parasite histones are produced in vivo in patients with 153 malaria and there are no data assessing the association between histones and clinical or 154 laboratory indicators of severity or coagulation and leak, nor data to assess whether 155 plasmodial histones bind in the vasculature at sites of sequestration. 156 157
Here we address these gaps. Using detailed laboratory, clinical and MRI imaging data we link 158 histone levels in the blood to fibrin formation, endothelial activation and thrombocytopenia 159 and to brain swelling and fatal outcome. Through post-mortem brain tissue samples from CM 160 cases we show marked correlation between sequestration and the deposition of histones on 161 the endothelial surface, and co-localisation with thrombosis and leak in the brain vasculature. 162 We then demonstrate a causal role of P. falciparum histones in these processes through ex 163 vivo experiments. 164 165
Methods 166 Patients and blood samples 167
Children aged 6 months -16 years were recruited at Queen Elizabeth Central Hospital, 168 Blantyre Malawi between January 2010 and August 2011. Inclusion criteria are described 169 previously (8) . Children who met WHO criteria for CM underwent funduscopic examination 170 by an ophthalmologist: characteristic retinal changes indicate sequestration of IE in the 171 brain(37) and distinguish retinopathy-positive CM with stringently defined CM (CM-pos) from 172 cases with retinopathy negative CM (CM-neg), who are more likely to have an alternative 173 diagnosis (1), to which malaria makes a variable contribution (38) and thus may have a 174 different coma aetiology. Venous blood was collected at admission into plain or sodium 175 citrate tubes and serum and plasma prepared as previously described (39), stored at -80°C 176 until assays were performed. Circulating histone levels were quantified by a custom 177
immunoblot assay (18) (19) (20) and Osteoprotegrin, Fibrin monomers, F1+2 fragment by ELISA as 178 described previously (8, 11, 40) . 179 180
MRI scans and scoring of brain swelling 181 MRI images were acquired using a 0.35-Tessla Signa Ovation Excite MRI scanner (General 182 Electric). Images were scored independently by two radiologists who were blinded to 183 patient disease group and outcome. A score from 1 -8 was assigned to each scan, based on 184 cerebral hemisphere swelling, using pre-specified criteria -described previously (3). We 185 divided patients into 4 groups on the basis of this 8-point score: Score 1-3, No brain 186 swelling; 4-5, mild brain swelling; 6, moderate brain swelling and 7-8, severe brain swelling. 187
A number of children did not have MRI scans. When this was because they recovered from 188 coma within 12 hours we deemed it likely that they did not have significant brain swelling 189 and included them in category 1. Other MRI scans were not performed for several reasons 190 (e.g. patient clinical unstable, equipment issues), we could not reasonably assign a category, 191 and missing data were handled by listwise deletion. 192 193 Isolation and purification of P. falciparum histones 194 ITG mature IE were lysed with saponin and P. falciparum histones (H2A, H2B, H3, H4) purified 195 using a Kit (Active Motif). Protein concentrations were determined by Biorad Protein Assay, 196 using bovine serum albumin and purified calf histones (Roche) standards and purity examined 197 by SDS-PAGE and Coomassie staining (>95% pure; Fig. S3 ) 198
Mass spectrometry sample preparation 199
Purified P. falciparum and human histones (New England Biolabs) (6µg), normal serum, 200
histone spiked serum and CM patient serum were separated by 15% SDS-PAGE and stained 201
with Coomassie brilliant blue. The excised gel slices (<35kDa) from SDS-PAGE, were cut into 202 1mm 3 plugs, transferred to a microtube and fully de-stained using 25mM Ambic alternately 203
with Ambic/MeCN (2:1). Cysteine reduction was performed by adding 100µL DTT solution 204
(1.5mg/mL) and incubated at 60°C for 60 min. Samples were centrifuged and the supernatant 205 was discarded. Alkylation was performed by the addition of 100µL iodoacetamide (10mg/mL) 206
for 45 min (protected from light). Samples were centrifuged and the supernatant discarded. 207
Gel plugs were then washed with Ambic (25mM) for 15min at 37°C. To fully dehydrate the gel 208 plugs, samples were washed with MeCN. In-gel digestion was performed by adding 100µL of 209 trypsin (12.5ng/µL in 25mM Ambic) to each sample with overnight incubation at 37°C, and 210 reactions terminated by the addition of 10µL formic acid (1% final concentration). The 211 solutions surrounding the gel plugs (containing the tryptic peptides) were retained for 212 analysis . To extract additional peptides from the gel plugs, a further incubation with a solution  213 containing water:MeCN:FA (50:49:1) and then MeCN:FA (80:19:1) was performed. Finally, 214
solutions were pooled and dried to a 10µL solution. 215 216
Liquid Chromatography-mass spectrometry analysis 217
Analysis was performed using an Ultimate 3000 RSLC™ nano system (Thermo Scientific, 218
Hemel Hempstead), coupled to a QExactive-Hf™ mass spectrometer (Thermo Scientific). 219
Samples were loaded onto a trapping column (Thermo Scientific, PepMap100, C18, 300 μm X 220 5 mm), using partial loop injection, for seven minutes at a flow rate of 9 μL/min with 0.1% 221
(v/v) FA. Samples were then resolved on the analytical column (Easy-Spray C18 75 µm x 500 222 mm 2 µm column) using a gradient of 97% A (0.1% formic acid) 3% B (99.9% ACN 0.1% formic 223 acid) to 60% A 40% B over 15 min at a flow rate of 300 nL min-1. The data-dependent program 224 used for data acquisition consisted of a 70,000 resolution full-scan MS scan (AGC set to 1 x 225 10 6 ions, with a maximum fill time of 20ms) the 10 most abundant peaks were selected for 226 MS/MS using a 35,000 resolution scan (AGC set to 1 x 10 5 ions with a maximum fill time of 227 100ms) with an ion-selection window of 3 m/z and a normalized collision energy of 28. To 228 avoid repeated selection of peptides for MS/MS the program used a 15 second dynamic 229 exclusion window. Sequence alignment was performed in PEAKs software (v8.5) against both 230 P. falciparum and Homo sapiens databases. Once species-specific peptides were identified 231 they were further verified using Skyline analysis software for quantification (comparisons 232 between the specific amino acid sequences of P. falciparum and Homo sapiens histone 233 proteins illustrated in Fig S4) . 234 235
Immunohistochemistry 236
Brain tissue samples of parietal cortex were collected at autopsy from Malawian children 237 dying with encephalopathic illness and were formalin fixed and paraffin embedded as 238 described previously (9). Based on clinical information and autopsy findings the cause of 239 death was determined for each case by a clinical pathologist. We used samples classified into 240 one of 3 overall categories as defined previously (1): 1) Definitive CM (CM1 and CM2) -241
children who met the case definition for CM during life and who at death had sequestration 242 of IE in cerebral vessels and in whom no alternative cause of death was identified at autopsy; 243 2) 'Faux CM' (CM3) -met the case definition for CM during life but who had no visible 244 sequestration of IE in cerebral vessels and in whom at autopsy another cause of coma and 245 death was identified in all cases; 3) Aparasitemic non-malarial coma comatose patients who 246 had no detectible malaria parasites in blood or tissue. 247 248
Cortical sections (4µm in thickness) were stained for histones and fibrinogen. Heat-induced 249 antigen retrieval in citrate buffer (pH 6.0) was performed prior to incubation with primary 250 antibodies: anti-histone H3 (Abcam); anti-Fibrinogen (Thermofisher)). Bound primary 251 antibody was detected with an immunoperoxidase kit (EnVision Plus; Dako). Negative 252 controls without primary antibody were used for all samples to confirm specificity. 253
Immunohistochemistry was performed on all cases by a single investigator blinded to 254 histologic diagnosis. Slides were scored by 3 investigators blinded to histological classification. 255 70 random vessels were scored from each slide. IE sequestration for each vessel was scored 256
as: negative (0); positive but <50% of the vessel lumen (+) or >50% of the vessel lumen (++). 257
Histone membrane staining for each vessel was scored as absent (0) to a control group). The association between histone levels and other variables was assessed 295
by linear regression and expressed as correlation coefficients. For ordered categorical slide 296 scoring data, the associations between histological classification, extent of sequestration and 297 degree of fibrinogen extravasation were assessed by use of ordinal logistic regression models, 298
controlling for clustering within cases and adjusting for any differences between scorers. All 299 tests were two-tailed with a conventional 5% alpha-level. 300 301
Results 302 Circulating concentrations of extracellular histones are elevated in cerebral malaria cases and 303 levels correlate with the degree of fibrin generation and with endothelial activation 304
Clinical characteristics of the patients are detailed in Table 1 . Compared with CM-pos, CM-305 neg patients had a higher haemoglobin and platelet count and lower lactate level and parasite 306 count. To explore whether histones are released in vivo and whether levels were associated 307 with diagnosis, we measured circulating histones in serum samples taken from patients on 308
admission. Histone concentrations were markedly higher in children with CM-pos than in 309 children with CM-neg, non-CM encephalopathy, uncomplicated malaria, non-severe febrile 310 illness or healthy controls ( Fig 1A) . These differences were not explained merely by an 311 association with parasite density as there was only weak correlation between extracellular 312 histone levels and peripheral parasite density (r=0.22 p=0.0044, Fig 1B) and there was no 313 correlation between histone and histidine rich protein 2 levels (PfHRP2, a released parasite 314 protein used as a marker of biomass [r=0.09, p=0.25]). 315 316
To explore histones as a possible trigger for coagulation activation in CM we assessed the 317 association between circulating histones and markers of in vivo fibrin formation and 318 coagulation activation (11). In CM-pos cases, plasma fibrin monomer concentrations 319 correlated with circulating histone levels (r=0.56; p=<0.001, Fig 1C) more strongly than with 320 (log) peripheral parasite density (r=0.34, p=<0.001), PfHRP2 (r=0.24, p=0.013), platelets (r=-321 0.18, p=0.2), lactate (r=0.33, p=<0.001), blood glucose (r=0.08 p= 0.58) or haemoglobin 322 (r=0.06, p=0.89). Circulating histone levels showed a moderate correlation with prothrombin 323 fragment F1+2 (a marker of thrombin generation (r=0.34, p=<0.001; Fig 1D) ). Hence 324 circulating histones better predict fibrin generation and coagulation activation than parasite 325 density or other markers of disease severity. 326 327
Histones cause Weibel Palade Body (WBP) exocytosis and thrombocytopenia in mice through 328 endothelial activation and increased platelet adhesion (25). Here circulating histone 329 concentration correlated negatively with platelet levels, weakly in the subgroup of children 330
with retinopathy positive CM (r= -0.22, p=0.0039 [in whom thrombocytopenia was nearly 331 universal]), but moderately when patients with retinopathy negative CM were also 332 considered (r= -0.41, p=<0.001; Fig 1E) . Endothelial activation and WPB exocytosis are well 333 established in CM including release of osteoprotegrin (OPG), which we have previously shown 334 correlates with thrombocytopenia (40). Here circulating histone concentration correlated 335 with plasma osteoprotegrin concentration (r = 0.54, p<0.001, Fig 1F) . These data show a 336 specific association between histones and CM-pos but not with CM-neg or aparasitaemic 337 encephalopathy and suggest a link between extracellular histones and critical factors involved 338 in clot formation and localization. 339 340
Association between histone levels, brain swelling and fatal outcome. 341
Given this association between histones and coagulopathy, a process implicated in brain 342 swelling (41) and death (8, 42) in CM, we assessed the correlation between histone levels and 343 fatal outcome and brain swelling. In children with CM-pos, the serum histone concentration 344 was significantly higher in patients who died (n = 24; geometric mean 35.7 µg/ml [18.6-68.6 345 µg/ml]; Fig 2A) than in patients who survived (n = 146; geometric mean 21.6 µg/ml [16.4-346 28.6 µg/ml]; p = 0.04). 347 348
In CM-pos cases histone levels were 3 times higher in children who had moderate brain 349 swelling (geometric mean 26.9 µg/ml; 95% CI 17.45 -41.42, p= 0.028 ) or severe brain 350 swelling (29.86 µg/ml; 95% CI 18.58 -47.97, p = 0.012) than in children who had no evidence 351 of brain swelling on MRI (8.79 µg/ml; 95% CI 3.09 -25.01) ( Fig 2B) . In comparison peripheral 352 parasite density, PfHRP2, lactate, platelet levels, and osteoprotegrin levels were not 353 significantly associated with brain swelling (Fig.S1 ). There was a significant association 354 between platelet levels and swelling and lactate levels and swelling when a less stringent 355 definition of CM was used (i.e. when both CM-pos and CM-neg cases were included, Figure  356 S2), this wider inclusion also increased the strength of association for histones ( Figure S2 ). 357
Taken together these data indicate a strong association between histone levels and the 358 degree of brain swelling over and above other laboratory factors associated with severity in 359 CM. 360 361
Detection of significant levels of P. falciparum histones in patient samples using mass 362 spectrometry 363
Owing to the highly conserved nature of histones, with >90% sequence homology between 364
Plasmodium and human histones, available antibodies react with both human and 365
Plasmodium histones (28). We developed a semi-quantitative mass spectrometry method 366 (outlined in Figure 3A ), to determine the proportion of parasitic and human histones within 367 patient samples. Using P. falciparum histones purified from culture (Fig. S3 ), and pure human 368 histones, we identified specific peptides for both H4 (Fig. 3B, C, Fig. S4 ) and H2A.Z (Fig. S4 ) 369
that distinguished between P. falciparum and human histones ( Fig. 3D, E) . We then applied 370 this method to serum samples from 10 children with CM-pos. P. falciparum and human 371
histones were identified in all 10 CM cases, with P. falciparum histones constituting a mean 372 of 51% (range 2% to 91%, Fig. 3F , G) of the total histone concentration. 373
374
Accumulation of histones at the endothelial surface in the brain in fatal cases is associated 375 with sequestration and with blood brain barrier breakdown 376
Histone mediated barrier disruption is caused by histones binding to the endothelium, 377
observed by histology in histone-infused mice (22). To explore whether extracellular histones 378
bind to the endothelium in CM we performed immunostaining for histones in post-mortem 379 brain samples from Malawian children (details of cases in Table S1 ). Compared with "faux 380 CM" (CM3) cases (n=6, Fig 4A) or non-CM cases (n=5) luminal histone staining was more 381 frequent and stronger in CM cases (CM1/2, n=15, Fig 4B) . Quantifying this by scoring with 382 observers blinded to diagnosis, strong membrane staining was markedly associated with 383 definitive CM when compared with faux CM (odds ratio [OR] 2.6; 95% Confidence Interval [CI] 384 1.7 -3.9; p<0.001) or non-CM (OR 7.2; 95% CI 5.0 -10.6; p<0.001; Fig 4C) . 385 386
Among definitive CM cases there was a strong association between histone membrane 387 staining and the presence of IE. This increased with more intense IE-sequestration: when 388 sequestration was present but in less than 50% of the vessel (+) the OR of histone membrane 389 staining being present was 5.2 (95% CI 2.8 -9.7, p<0.001; Fig 4D) ; when greater than 50% of 390 the vessel contained sequestered IE (++) the OR for the presence of histone staining was 16.9 391 (95% CI 9.2 -31.3; p<0.001). 392 393
Histone staining was also strongly correlated with areas of BBB breakdown, demonstrated by 394 staining for fibrinogen extravasation ( Fig 4E) : weak histone staining was associated with an 395 OR of 2.8 for the presence of fibrinogen extravasation (95% CI 1.6 -5.0; p=<0.001, 4F) and 396 strong histone staining with an OR of 4.5 for fibrinogen extravasation (95% CI 1.8 -11.4; 397 p=0.001), as shown in fig.4H as "% of vessels with leak". Histone staining was also observed 398 to co-localize with thrombi ( Fig 4G) and with ring hemorrhages ( Fig 4H) . 399 400
Purified P. falciparum histones and serum from CM cases induce endothelial damage and 401 barrier disruption 402
Mammalian histones directly induce endothelial cell membrane damage and barrier 403 disruption on human vein umbilical vein EC (16, 18) and P. falciparum histones induce damage 404 in dermal and lung EC (28). To investigate the potential relevance of this in the brain, we 405 tested whether purified P. falciparum histones cause cell damage and leak on primary human 406 brain microvascular EC (HBMEC). P. falciparum histones induced significant cellular toxicity 407 (n=3 for each condition, Fig. 5A, B ) similar to the effects seen with mammalian histones (16, 408 18). To demonstrate that this effect was specifically induced by histones, and not a 409 contaminant, we used an anti-histone single-chain Fragment variable (ahscFv), previously 410
shown to inhibit histone toxicity (18, 43) . ahscFV abrogated histone-induced toxicity (Fig. 5A ). 411
Non-anti-coagulant heparin, a potential treatment with minimal toxicity that prevents toxicity 412 of mammalian histones (24), also prevented P. falciparum histone toxicity on HBMEC (Fig.  413  5A) . 414
415
To investigate whether circulating histones from patients induce membrane toxicity, we 416 incubated patient serum with HBMEC. Serum from CM-pos cases with elevated histones 417 (histone concentration >100ug/ml; n=5) induced significant cellular toxicity, whereas serum 418 from CM-pos cases without substantially elevated histones levels (histone concentration 419 <25ug/ml) did not (n=3), nor did samples from children with uncomplicated malaria (n=3), 420 mild non-malarial febrile illness (n=3), non-malarial encephalopathy (n=3) or retinopathy 421 negative CM (n=3; Figure 5B ). Serum-induced toxicity was abrogated by ahscFv treatment, 422
supporting a causal link with histones in the serum (Fig. 5A, B ). 423 424
We next investigated the effect of purified P. falciparum histones and patient serum on 425 barrier integrity. Similar to human histones, P. falciparum histones induced rapid barrier 426 disruption in HBMEC. This leak was reversed by ahscFv ( Fig S5) . Similarly, serum from CM-pos 427 cases with high histone levels (n=3) induced leak, but serum from CM-neg cases and other 428 control groups (all n=3) did not. Leak in the CM-pos cases was abrogated by ahscFV, also 429 supporting that histones in the serum were causal in this leak (Fig. 5C ). 430 431
Given the correlation between histones and thrombocytopenia in CM (Fig. 1E) we 432 investigated whether P. falciparum histones also cause platelet aggregation. Incubation of 433 purified P. falciparum histones with platelet rich plasma from normal healthy controls 434 resulted in dose dependent platelet aggregation, inhibited with ahscFv treatment (Fig. 5D ). 435 436
Discussion 437
A number of factors released from IE have been shown to cause endothelial damage or leak 438
in vitro including glycosylphosphatidylinositol (44), extracellular vesicles (45), hemozoin and 439
PfHRP2. IE-EC receptor-ligand interactions also cause endothelial perturbation (46-48). While 440 it seems likely that CM pathogenesis constitutes a combination of interacting factors, rather 441 than a single toxin or ligand (49, 50), we sought a factor that is necessary for CM vascular 442 pathology and targetable with a safe and deployable treatment. Histones were a compelling 443 candidate. Firstly because of the strong parallels between the clinicopathological features of 444 histone-induced vascular pathology in other conditions and those in malaria. Secondly, 445
because the sequestration of histone-packed IE in tissues would predict substantial 446 concentration of histones being extruded to the endothelial surface. Thirdly because histones 447 are a plausible target for an adjunctive therapy; treatments targeted against histones are 448 protective in animal models of sepsis and trauma, even though extracellular histones are 449 clearly not the sole factor contributing to pathogenesis in either of these conditions. 450 451
Our data provide evidence for histones as a necessary mediator of the vascular pathology in 452 the brain in CM that link causal data from ex vivo experiments (patient serum directly causes 453 leak and toxicity, which is reversed by blocking histones) to multi-model observations in a 454 rigorously defined patient cohort. Correlation between histones levels, diagnosis, fatal 455 outcome, thrombocytopenia and fibrin production imply a role for histones in death and in 456 key pathogenetic processes. Employing MRI scans and a grading system we established a 457 correlation between serum histone levels and the level of brain swelling in children. We then 458
showed that a significant proportion of histones were of parasite origin. Although human 459
histones are also toxic, they are produced by diverse activated or damaged cells and might be 460 a bystander event, triggered distant from sites of sequestration and vascular pathology. In 461 contrast, parasite histones in the systemic circulation strongly suggest downstream detection 462 of histones released from rupturing mature schizonts, in which histones are concentrated 16-463 24-fold, occurring almost exclusively in sequestered IE. Examination of histological staining in 464 post-mortem CM brain samples supported this paradigm. Extracellular histones were bound 465 to the EC membrane, more frequently in CM cases than controls and spatially associated with 466 the presence of sequestered IE and with areas of fibrinogen leak and thrombosis. 467 468
To confirm whether plasmodial histones might be causal in these pathogenetic events, we 469 purified P. falciparum histones from parasites grown in culture and showed that they induced 470 membrane damage and leak in primary HBMEC and platelet aggregation in platelets from 471 healthy donors. These effects were prevented by specific ahscFv. Patient serum from CM 472 cases with high levels of histones also induced EC membrane toxicity and leak. Both were 473 blocked by pre-incubation with ahscFv, indicating that the effects were caused by active 474 histones in serum. Heparins, including non-anticoagulant heparins have been shown to 475 neutralize the effects of mammalian histones and may represent promising therapies. As a 476 proof of concept, we showed that non-anticoagulant heparin prevented toxicity from P. 477 falciparum histones. Taken together, these data show that P. falciparum histones are 478 produced at significant levels in vivo, that they circulate in an active form, show a causal role 479 for histones from patient serum samples ex vivo in processes leading to CM pathogenesis and 480 provide multiple points of evidence supporting a role of histones in key disease processes in 481 patients. 482 483
The locations of plasmodial histone production and what we know about modifiers of histone 484 response fit well with the non-uniform pattern of vascular involvement in CM, whereby 485 coagulopathy and leak are localized to sites of IE sequestration and in particular to the brain. 486 It is notable that the median concentration of histones in the serum in CM-pos cases was 487 24.6µg/ ml, and that toxicity to HBMEC in our assay was only seen at histones concentrations 488 of >50µg/ ml (similar to mammalian histones and to experiments using purified exogenous 489 histone infusion in mice (16, 22, 28) ). The implication being that in most patients with CM, 490 histone levels in the circulation do not reach levels sufficient to cause systemic toxicity. This 491 is in keeping with the observed clinical pattern of disease in CM in African children: deep coma 492 and marked cerebral irritability, generally without multi-organ failure (14) or systemic 493 coagulopathy (11). In contrast it seems highly plausible that P. falciparum histones 494
concentrate several fold at sites of intense sequestration (Fig. 3B ) and cross this toxic 495 threshold. We hypothesize that the brain is particularly vulnerable to histone toxicity because 496 of reduced capacity to produce aPC. This would not be expected to manifest in conditions 497 involving release of histones from immune-activated cells such as in sepsis and trauma, given 498 that the brain is an immune-privileged site (51). The paradigm in CM is different; parasite 499 histones reach high levels in the brain through IE sequestration. Moreover, IE sequestration 500 in the brain may itself impair aPC production -firstly because IE reduce surface 501 thrombomodulin and EPCR, putatively by receptor cleavage (8, 15) . Secondly, parasite 502 variants associated with the development of CM (expressing domain cassette 8 [DC8]) reduce 503 aPC production, by binding to EPCR and inhibiting its activity (52). DC8 variants also show a 504 tropism for brain endothelium (34, 52, 53) . Hence parasites in CM patients may be more likely 505
to concentrate plasmodial histones in the brain, through sequestration, and simultaneously 506 may prevent their breakdown, through inhibiting aPC production. In support of this, DC8 507 expressing variants are associated with both thrombocytopenia and brain swelling (48); aPC 508 inhibition potentially increasing both histone-induced platelet aggregation and histone-509 induced endothelial leak. It is notable that histones are implicated in neurotoxicity and 510 ischemic damage in neurodegenerative conditions and stroke, and that in animal models 511 these effects are reversed by aPC (54-56). 512 513
Our study has several limitations. Firstly, our study is in human patients. While generally a 514 strength, this leads to marked heterogeneity, including in variables that might affect histone 515 levels, such as length of illness and timing of antimalarial administration. Further we took 516 blood from each patient at only one timepoint, representing a snapshot in a dynamic disease 517 process. This precluded examination of the temporal association between histone levels and 518 other variables. Secondly, while the association between histone binding and sequestration 519 and the finding that 51% of histones in serum were of parasite origin are both highly 520
suggestive of a parasite origin for luminal histones, we did not prove this. Nonetheless 521 concentration of host histones at sites of IE sequestration would also be predicted to have 522 similar effects and to respond to similar treatments. 523 524
Given that a significant proportion of histones detected in blood are of parasite origin it is 525 notable that histone levels do not correlate well with parasitemia or PfHRP2. This may reflect 526 the limitations of each of these assays, used at a single time point, to determine total parasite 527 biomass. Firstly, our main assay to determine histone levels does not distinguish human from 528 parasite histones. Serum histone levels are likely to be a function of production, breakdown 529 and luminal binding and hence it is unclear how accurately serum histone levels of either 530 species correlate with total production. Secondly peripheral parasitemia is a poor predictor 531 of total parasite biomass: sequestered IE do not circulate, and so the concentration of 532 parasites detectable in the periphery fluctuates markedly depending on the stage of the 533 majority of the parasites in an individual patient. Thirdly, PfHRP2, a soluble parasite factor, 534
has a long half-life and therefore its concentration in serum is a function of parasite biomass 535 and duration of infection. While PfHRP2 is a predictor of parasite biomass and correlates with 536 disease severity in several populations (57, 58) , among Malawian children with CM, serum 537 PfHRP2 levels do not correlate well with markers of severity (such as lactate or 538 thrombocytopenia) or with outcome (59). 539 540
Further work is warranted to explore the biology and timing of plasmodial histone release 541 and the mechanism of action of plasmodial histones in greater detail. A specific antibody 542 against P. falciparum histone would be useful to differentiate P. falciparum histone levels in 543 serum and in tissue. It remains to be determined whether agents that neutralize or degrade 544 histones can reduce brain swelling during the critical 24 hours after hospital admission and 545 thereby improve outcome in CM. Potential agents include aPC or heparin (24, 60, 61). 546
Modified non-anticoagulant heparins are a rational first choice, particularly given their use in 547 critically ill patients with a variety of inflammatory diseases (61) and in patients with sickle 548 cell crisis (62). There is a planned phase II study in patients to use a modified heparin to 549 reverse binding and rosetting in malaria. A different dosing regimen is likely to be needed to 550 reverse the effects of histones than to block binding, which would require further 551 investigation. However, the possibility that modified heparins could be synergistic in malaria 552 -both reducing binding and neutralizing heparins -make the potential benefits more 553
compelling. Finally, since cells in all eukaryotic organisms contain histones it will be important 554
to explore whether parasite histones contribute to pathogenesis in other parasitic infections. 555 556 557
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